Diagnosis and management of acute promyelocytic leukemia: Brazilian consensus guidelines 2024 on behalf of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy Lorena Lobo de Figueiredo-Pontes; Luiz Fernando Bazzo Catto; Maria de Lourdes Lopes Ferrari Chauffaille; Katia Borgia Barbosa Pagnano; Maria Isabel Ayrosa Madeira; Elenaide Coutinho Nunes; Nelson Hamerschlak; Marcela Cavalcante de Andrade Silva; Thiago Xavier Carneiro; Teresa Cristina Bortolheiro; Tiago Thalles de Freitas; Rosane Isabel Bittencourt; Evandro Maranhão Fagundes; Eduardo Magalhães Rego;

GATA2 variants in patients with non-tuberculous mycobacterial or fungal infections without known immunodeficiencies Daniela P. Mendes-de-Almeida; Francianne G. Andrade; Filipe V. dos Santos-Bueno; Dayvison F. Saraiva Freitas; Sheila C. Soares-Lima; Rosely M. Zancopé-Oliveira; Maria S. Pombo-de-Oliveira;

Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia Sergio Rodríguez-Rodríguez; Lorena Guerrero-Torres; María José Díaz-Huízar; Alan Pomerantz; María del Pilar Ortíz-Vilchis; Roberta Demichelis-Gómez;